The treatment of Age-Related Cognitive Decline & Cancer Risk Reduction with vitamins
Age-Related Cognitive Decline and Cancer Risk Reduction: Mitamins custom make quality formulas for the treatment of Age-Related Cognitive Decline & Cancer Risk Reduction with vitamins. A Age-Related Cognitive Decline & Cancer Risk Reduction formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Name Your Supplement Bottle - Just how you like it
Your Perfect Supplement - Custom-made just for you
Age-Related Cognitive Decline and Cancer Risk Reduction
Serving Size:4-5
Age-Related Cognitive Decline and Cancer Risk Reduction Formulas Details
Latest Health Related News:
GSK Submits Cervarix? Licence Application To Japan's Health AuthoritiesGlaxoSmithKline (GSK) announced that it has submitted a licence application for its cervical cancer candidate vaccine Cervarix? to the Japanese Ministry of Health, Labor and Welfare (MHLW). This is the first vaccine for the prevention of cervical cancer to be filed for approval in Japan.GSK's cervical cancer candidate vaccine is formulated with a novel proprietary adjuvant system called AS04, intended to enhance immune response and increase duration of protection.
Too Few Europeans Undergo Colorectal Cancer And Prostate Checks Ups, Eurobarometer RevealsAlthough European citizens appear to be generally aware of the importance of preventive medical checkups, the vast majority of them do not undergo colorectal cancer or prostate tests, an EU wide survey reveals. The Eurobarometer on "Health in the European Union," published recently, which marks the European Prostate Awareness Day, indicates that only 13% of European men took the Prostate Specific Antigen Tests and only 8% of all respondents the colorectal cancer test.
This information concerning the support of Age-Related Cognitive Decline and Cancer Risk Reduction treatments provide basic knowledge which should always be discussed with your own health practitioner.